Alvarez-Martin C, Ribera A, Marsal JR, Ariza-Sole A, Perez-Hoyos S, Oristrell G, Soriano-Colome T, Romaguera R, Pijoan JI, Lidon RM, Mauri J, Ferreira-Gonzalez I. Dynamics of emergency cardiovascular hospital admissions and in-hospital mortality during the COVID-19 pandemic: time series analysis and impact of socioeconomic factors. Front. Cardiovasc. Med. 2022 Apr 26. doi: 10.3389/fcvm.2022.827212
Singh M, Rebordosa C, Bernholz J, Sharma N. Epidemiology and genetics of cystic fibrosis in Asia: in preparation for the next-generation treatments. Respirology. 2015 Nov 6;20(8):1172-81. doi: 10.1111/resp.12656
Ganderton L, Jenkins S, McKenna SP, Gain K, Fowler R, Twiss J, Gabbay E. Validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for the Australian and New Zealand population. Respirology. 2011 Nov;16(8):1235-40. doi: 10.1111/j.1440-1843.2011.02030.x
Hirsch IB, Xu Y, Davis KL, Calingaert B. Patient factors associated with glucagonlike peptide 1 receptor agonist use with and without insulin. Endocr Pract. 2011 Sep 1;17(5):707-16.
Tunceli K, Pladevall-Vila M, Williams LK, Divine GW, Simpkins JC, Nag SS, Sajjan SG, Kamal-Bahl SJ, Alexander CM, Lafata JE. Trends in lipid management among patients with diabetes. Endocr Pract. 2006 Jul;12(4):380-7.